Form 4: Alignment Healthcare President Sells Shares

Alignment Healthcare's President, Dawn C. Maroney, sold 30,000 shares of common stock through a pre-arranged 10b5-1 plan.

Summary

• Dawn C. Maroney, President of Alignment Healthcare, Inc., sold a total of 30,000 shares of common stock.
• The sales occurred on January 15, 2026, under a Rule 10b5-1 trading plan adopted on May 22, 2025.
• The shares were sold in two tranches: 15,129 shares at a weighted-average price of $22.1875 (ranging from $21.58 to $22.57) and 14,871 shares at a weighted-average price of $22.781 (ranging from $22.58 to $22.98).
• Following these transactions, Maroney beneficially owns 1,027,015 shares of Alignment Healthcare common stock.

Sentiment

Score: 4

Explanation: While the sale was pre-planned under a 10b5-1 plan, insider selling, especially by a high-ranking executive, can still be perceived negatively by the market, potentially indicating a belief that the stock is fully valued or that the executive is diversifying. However, the executive retains a substantial holding.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned sale rather than a reaction to immediate news.
• The reporting person still retains a significant beneficial ownership of 1,027,015 shares after the sales, demonstrating continued alignment with shareholder interests.

Negatives

• President Dawn C. Maroney sold 30,000 shares of common stock.
• Insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a lack of confidence or a signal that the stock may be fully valued, potentially leading to negative sentiment.

Risks

• Potential negative market perception due to insider selling, which could put downward pressure on the stock price.

Future Outlook

NA

Industry Context

NA

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• Sale of 30,000 shares of common stock by Dawn C. Maroney, President of Alignment Healthcare, Inc., to diversify personal holdings as per a Rule 10b5-1 plan.

Stakeholder Impact

• Shareholders: Potential negative sentiment due to insider selling, though mitigated by the pre-arranged 10b5-1 plan.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Next Steps

• NA

Key Dates

Recommendation

The sale of shares by a key executive, even under a Rule 10b5-1 plan, can create negative market sentiment. However, the pre-planned nature of the sale suggests it is not a reaction to immediate adverse news, and the executive retains a significant stake in the company. Investors should monitor future insider activity and company performance rather than reacting solely to this single transaction.

Keywords

Alignment Healthcare, ALHC, insider trading, Form 4, stock sale, executive compensation, 10b5-1 plan, Dawn Maroney